CDH1 and neoplasm: To further investigate the molecular signaling pathways of MMP inhibition by cysteamine treatment, we conducted western blots for transglutaminase 2 (TGM2) and extracellular matrix proteins such as N-cadherin (an invasion promoter) and E-cadherin (a tumor suppressor).